Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT00407732
Eligibility Criteria:
Inclusion Criteria:
* Patient has confirmed diagnosis of HCV;
* Patient has expressed an interest in undergoing interferon treatment;
* Patient is deferred from interferon therapy for psychiatric, alcohol use, or other psychosocial issues;
* Patient must be completely medically cleared by the hepatologist with no outstanding medical conditions that would deem them ineligible from treatment;
* Patient must have only psychiatric issues and/or substance use issues; but otherwise no other contraindications for treatment.
Exclusion Criteria:
* Patient has a diagnosis of schizophrenia, psychosis;
* Patient resides in a psychiatric residential facility;
* Patient attempted suicide in the past five years;
* Patient is a current intravenous drug user;
* Patient is cognitively or decisionally-impaired due to brain disease or injury;
* Patient has advanced liver disease that precludes them from interferon treatment;
* Patient has other medical comorbidities that may exclude them from interferon treatment;
* Patient does not want to pursue interferon treatment at the present time;
* Patient has significant financial constraints, such as no insurance or homelessness, that would prevent them acquiring mental health or substance abuse services;
* No access to telephone service;
* Non-English speaking.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00407732
Study Brief:
Protocol Section:
NCT00407732